| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |